Day: March 3, 2019

FDA Approval Expected Monday of Ketamine-derived “Spravato”

      TAKE HOME POINTS: SpravatoTM, a form of ketamine, will be FDA approved on Monday for Treatment Resistant Depression and for Major Depression with suicidality. FDA approval will result in insurance coverage for this form of ketamine, for this purpose, which will make it affordable for millions of suffering patients. Although it is...

MORE

Popular Blog Posts

“What will my ketamine infusion feel like?”

Ketamine therapy for OCD

At our Boulder Mind Care (in Boulder) and Transcendent Ketamine of Colorado (in Fort Collins), we provide dramatic relief…

LEARN MORE

The Denver Post features Transcendent Ketamine of Colorado & Boulder Mind Care December 24 2023

We were honored to be recently featured recently in The Denver Post, at https://www.denverpost.com/2022/12/24/ketamine-infusions-depression-chronic-pain-colorado. It is always beneficial when…

LEARN MORE

The Pandemic, Teen Depression, and Suicide Risk

Measures to contain the spread of coronavirus have inadvertently increased teen depression and suicide risk, as demonstrated by Mayne…

LEARN MORE

Ketamine Infusion Therapy for PTSD – Results of an Important New Study

A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her…

LEARN MORE

Ketamine – The Most Powerful Treatment For Depression Yet Invented

Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…

LEARN MORE